- Trust is infrastructure. And Africa’s fintech reckoning proves it - Salvador Anglada, Optasia Group CEO
- Africa’s cement industry and the push for energy security - Krzysztof Lokaj, Wärtsilä Energy Africa Development Manager
- The 2026 Budget doubled your single discretionary allowance - Harry Scherzer, CEO, Future Forex
- Exclusive Convo: Nafissatou Fall Diagne, Managing Director, Development Finance Advisory
- Exclusive Interview: Sotiguy Coulibaly, Chief Executive Officer, KERALES FINANCE
FDA Moving at ‘Lightning Speed’ on Gilead Virus Drug, Hahn Says
NEW YORK (Capital Markets in Africa) — The Food and Drug Administration is moving at “lightning speed” to review data on Gilead Sciences Inc.’s experimental Covid-19 treatment remdesivir, Commissioner Stephen Hahn said, after encouraging results emerged from a key U.S. trial. “We’re working with the company to emphasize the necessity of speed while at the same time to understand the data,” Hahn said in an interview. “There will be a lot of factors that go…
Read More







